United States
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB
(Mark one)
   X     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
  ---    EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 2003
                                       or
         TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
  ---    EXCHANGE ACT OF 1934

              For the transition period from -------- to ----------

                         Commission File Number 0-13316

                                LASER CORPORATION
                                -----------------
        (Exact name of small business issuer as specified in its charter)

                  Utah                                          87-0395567
            -----------------------                       ------------------
           (State of Incorporation)                        (I.R.S. Employer
                                                          Identification No.)
       2500 South Decker Lake Blvd. #6
            Salt Lake City, UT                                  84119
       -------------------------------                         ----------
           (Address of principal                               (Zip Code)
              executive office)

                                 (801) 972-1311
                                 --------------
                (Issuer's telephone number, including area code)

                                 Not Applicable
                                 --------------
              (Former name, former address and former fiscal year,
                          if changed since last report)

Check  whether  the issuer  (1) has filed all  reports  required  to be filed by
Section 13 or 15(d) of the Securities  Exchange Act of 1934 during the preceding
12 months (or for such shorter  period that the  registrant was required to file
such reports) and (2) has been subject to such filing  requirements for the past
90 days.
                       Yes   X        No
                           -----         -----

State the number of shares outstanding of each of the issuer's classes of common
stock, as of the latest practical date.

Common Stock, .05 Par Value -- 1,643,073 shares as of August 11, 2003


<PAGE>
                                      INDEX

                       LASER CORPORATION AND SUBSIDIARIES


PART I.  FINANCIAL INFORMATION
------------------------------

Item 1.  Financial Statements (Unaudited)

         Consolidated Condensed Balance Sheets - June 30, 2003.  (Unaudited)

         Consolidated Condensed Statements of Operations - Three months ended
         June 30, 2003 and 2002; Six months ended June 30, 2003 and 2002.
         (Unaudited)

         Consolidated Condensed Statements of Cash Flows - Six months ended
         June 30, 2003 and 2002.  (Unaudited)

         Notes to Consolidated Condensed Financial Statements - June 30, 2003.

Item 2.  Management's Discussion and Analysis.

Item 3.  Controls and Procedures


PART II. OTHER INFORMATION
--------------------------

Item 1.  Legal Proceedings

Item 5.  Other Information

Item 6.  Exhibits and Reports on Form 8-K



SIGNATURES
----------

CERTIFICATION
-------------

EXHIBITS
--------


                                        2

<PAGE>

PART I. FINANCIAL INFORMATION
Item 1.

                       LASER CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED CONDENSED BALANCE SHEETS

                                                                     June 30,
ASSETS                                                                 2003
------                                                              (Unaudited)
                                                                    -----------
CURRENT ASSETS
  Cash and cash equivalents                                         $     5,960
  Receivables, net                                                       18,050
  Inventories                                                            25,123
  Assets from discontinued operations                                    58,025
                                                                    -----------
        Total Current Assets                                            107,158
                                                                    -----------

NON-CURRENT ASSETS
  Equipment and leasehold improvements, net                              24,088
                                                                    $   131,246
                                                                    ===========
LIABILITIES AND
---------------
STOCKHOLDERS' DEFICIT
---------------------

CURRENT LIABILITIES
  Accounts payable                                                  $   536,998
  Accrued expenses                                                      180,931
  Accrued warranty expense                                               50,000
  Liabilities from discontinued operations                              624,883
  Current notes payable                                                 500,000
                                                                    -----------
      Total Current Liabilities                                       1,892,812
                                                                    -----------

LONG-TERM DEBT                                                               --
                                                                    -----------
      Total Liabilities                                             $ 1,892,812
                                                                    -----------

COMMITMENTS AND CONTINGENCIES                                                --

STOCKHOLDERS'   DEFICIT
  Preferred Stock, no par value, 10,000,000 shares
     authorized; no shares issued                                            --
  Common Stock, $.05 par value, 40,000,000 shares
     authorized; 1,643,073 shares
     issued and outstanding                                              82,154
  Additional paid-in capital                                          2,168,350
  Deferred Compensation                                                (136,800)
  Accumulated deficit                                                (3,875,270)
                                                                    -----------

       Total Stockholders' Deficit                                   (1,761,566)
                                                                    -----------

                                                                    $   131,246
                                                                    ===========


           See accompanying notes to consolidated financial statements


                                       3

<PAGE>


                       LASER CORPORATION AND SUBSIDIARIES
                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                   Three months ended                 Six months ended
                                               ----------------------------     ---------------------------
                                                June 30,         June 30,        June 30,        June 30,
                                                  2003             2002            2003            2002
                                               ------------    ------------    ------------    ------------
<S>                                            <C>             <C>             <C>              <C>
REVENUES:
  Net sales                                    $     40,346    $     35,764    $     77,543     $   224,455
  Interest and other income                              --               3              --               5
                                               ------------    ------------    ------------    ------------
                                                     40,346          35,767          77,543         224,460
COSTS AND EXPENSES:
  Cost of sales                                      38,563          53,102         100,349         237,430
  Selling, general and
    administrative                                   58,070          95,335          97,342         194,633
  Research and development                               --              --              --              --
  Royalties                                              --              --              --              --
  Interest                                            9,155           8,750          17,911          17,500
                                               ------------    ------------    ------------    ------------
             Total Operating Expenses               105,788         157,187         215,602        449,563
                                               ------------    ------------    ------------    ------------

LOSS FROM OPERATIONS
  BEFORE INCOME TAXES                               (65,442)       (121,420)       (138,059)       (225,103)
Income Tax Benefit                                       --              --              --              --
                                               ------------    ------------    ------------    ------------
LOSS FROM CONTINUING
OPERATIONS                                          (65,442)       (121,420)       (138,059)       (225,103)

(LOSS) INCOME FROM DISCONTINUED OPERATIONS,
Net of Income Taxes                                (336,971)         50,237        (483,441)         72,352
                                               ------------    ------------    ------------    ------------
 NET LOSS                                      $   (402,413)   $    (71,183)   $   (621,500)   $   (152,751)
                                               ============    ============    ============    ============

Loss Per Share from Continuing
Operations - Basic and Diluted                 $      ( .04)   $      ( .07)   $      ( .08)   $      ( .14)

(Loss) Income Per Share from
Discontinued Operations
  - Basic and Diluted                          $      ( .20)   $        .03    $      ( .30)   $        .05
                                               ------------    ------------    ------------    ------------

TOTAL NET LOSS PER SHARE
  - Basic and Diluted                          $      ( .24)   $      ( .04)   $      ( .38)   $      ( .09)
                                               ============    ============    =============   ============

Weighted average number of shares
of Common Stock outstanding
      - Basic and Diluted                         1,643,000       1,643,000       1,643,000       1,641,000
                                               ============    ============    ============    ============
</TABLE>


           See accompanying notes to consolidated financial statements


                                        4

<PAGE>
                       LASER CORPORATION AND SUBSIDIARIES
                 CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
                     SIX MONTHS ENDED JUNE 30, 2003 AND 2002
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                    2003               2002
                                                                                ------------      -------------
CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                             <C>               <C>
  Net loss                                                                      $   (621,500)     $    (152,751)

  Adjustments to reconcile net loss to net cash (used in)
    provided from operating activities:
      Depreciation and amortization                                                   14,844             29,605
      Provision for losses on accounts receivable                                        308              4,977
      Gain on sale of assets                                                         (12,946)                --
      Impairment of assets from discontinued operations                              140,053                 --
  (Increase) decrease in:
      Receivables                                                                       (378)          (202,766)
      Inventories                                                                     95,031            164,147
      Other assets                                                                    31,416             (3,527)
  Increase (decrease) in:
      Accounts payable and accrued expenses                                          331,840            178,419
                                                                                ------------      -------------

                 Net cash (used in) provided by operating activities                 (21,332)            18,104
                                                                                ------------      -------------

CASH FLOWS FROM INVESTING ACTIVITIES:
       Proceeds from the sale of property and equipment                               26,926                 --
                                                                                ------------      -------------
                  Net cash provided by investing activities                           26,926                 --
                                                                                ------------      -------------

CASH FLOWS FROM FINANCING ACTIVITIES:
       Payments on Capital Leases                                                     (3,172)            (5,825)
                                                                                ------------      -------------
                  Net Cash (used in) financing activities                             (3,172)            (5,825)
                                                                                ------------      -------------

NET INCREASE IN CASH AND CASH EQUIVALENTS                                              2,422             12,279

CASH AND CASH EQUIVALENTS, BEG. OF PERIOD                                             14,592             26,837
        Cash and cash equivalents allocated to discontinued operations               (11,054)           (25,339)
                                                                                ------------      -------------

CASH AND CASH EQUIVALENTS, END OF PERIOD                                        $      5,960      $      13,777
                                                                                ============      =============
</TABLE>


           See accompanying notes to consolidated financial statements


                                        5

<PAGE>

                       LASER CORPORATION AND SUBSIDIARIES
             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
                                  June 30, 2003


NOTE A - BASIS OF PRESENTATION

         The accompanying  unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial  information  and the  instructions  to Form  10-QSB  and  Rule 310 of
Regulation  S-B.  Accordingly,  they do not include all of the  information  and
footnote disclosures required by accounting principles generally accepted in the
United  States  of  America.  In the  opinion  of  management,  all  adjustments
(consisting only of normal recurring accruals)  considered  necessary for a fair
presentation have been included.  Operating results for the three months and the
six months  ended June 30, 2003 are not  necessarily  indicative  of the results
that  may be  expected  for the year  ending  December  31,  2003.  For  further
information,  refer  to the  consolidated  financial  statements  and  footnotes
thereto for the year ended  December 31, 2002 included in the  Company's  Annual
Report on Form 10-KSB (file number 0-13316).

NOTE B - GOING CONCERN

         The  accompanying  financial  statements  have been prepared  under the
assumption  that the Company will continue as a going concern.  Such  assumption
contemplates  the  realization of assets and the  satisfaction of liabilities in
the normal course of business. For the six-month period ended June 30, 2003, and
the years ended  December  31, 2002 and 2001,  the  Company  incurred  losses of
($621,500),  ($420,745) and ($641,712),  respectively.  For the six month period
ended June 30, 2003,  and for the years ended  December 31, 2002,  and 2001, the
Company  has  also  experienced  net  cash  inflows  (outflows)  from  operating
activities of ($21,332),  ($1,309) and $16,389.  The financial statements do not
include any adjustments  that might be necessary should the Company be unable to
continue as a going concern.  The Company's  continuation  as a going concern is
dependent  upon  its  ability  to  generate  sufficient  cash  flow to meet  its
obligations  on a  timely  basis,  to  obtain  additional  financing  as  may be
required,  and  ultimately to attain  profitability.  Potential  sources of cash
include external debt and the sale of new shares of company stock or alternative
methods  such as  mergers  or sale  transactions.  No  assurances  can be given,
however,  that the Company will be able to obtain any of these potential sources
of cash.


NOTE C - RECLASSIFICATIONS

         Certain 2002  financial  statement  amounts have been  reclassified  to
conform to 2003 presentations.



                                       6
<PAGE>

NOTE D - ACCRUED EXPENSES

         Other accrued expenses consist of the following at June 30, 2003:

          Accrued interest                $ 111,616
          Trade Show fees                    39,507
          Accounting fees                    13,717
          Directors fees                     10,000
          Other                               6,091
                                          ---------
                                          $ 180,931
                                          =========

NOTE E - WEIGHTED AVERAGE SHARES

         The computation of basic loss per common share is based on the weighted
average number of shares outstanding during each year.

         The  computation  of diluted  earnings per common share is based on the
weighted average number of common shares  outstanding  during the year, plus the
common stock equivalents that would arise from the exercise of stock options and
warrants  outstanding,  using the treasury  stock method and the average  market
price per share during the year.  Options to purchase 186,000 and 290,084 shares
of common stock at prices ranging from $.10 to $6.06 per share were  outstanding
at June 30, 2003 and 2002,  respectively,  but were not  included in the diluted
loss per share calculation because the effect would have been antidilutive.

NOTE F - STOCK COMPENSATION

         The Company accounts for stock-based compensation under the recognition
and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to
Employees,  and related  Interpretations.  No stock-based employee  compensation
cost is reflected in net income  (loss),  as all options  vested had an exercise
price equal to or greater than the market value of the  underlying  common stock
on the date of grant.  No options were issued or vested  during the three or six
months ended June 30, 2003 and 2002, therefore,  there would be no effect on net
income  and  earnings  per  share if the  Company  had  applied  the fair  value
recognition  provisions of FASB Statement No. 123,  Accounting  for  Stock-Based
Compensation, to stock-based employee compensation.

NOTE G - SUPPLEMENTAL CASH FLOW INFORMATION

         During  the six  months  ended  June 30,  2003,  the  Company  returned
inventory  to a supplier in the amount of $72,200 and  recorded a  corresponding
reduction in accounts  payable.  The Company also  exercised its right of offset
with certain accounts receivable and accounts payable to related parties,  which
reduced accounts receivable and accounts payable by $438,272.

         During the  quarter  ended June 30,  2002,  the Company  issued  11,716
shares of common  stock to two board  members in exchange for $20,000 of accrued
director's fees.


                                        7
<PAGE>

         Actual cash paid for interest and income taxes are as follows:

                                                      Six Months
                                                     Ended June 30,
                                                 2003             2002
                                                 ----             ----

                        Interest                  327              2,304
                                                  ---              -----
                        Income Taxes               --                 --
                                                  ---              -----

NOTE H - DISCONTINUED OPERATIONS

         Due to the lack of orders  for the  Company's  laser  products  and the
resulting lack of income and cash flow, on April 7, 2003, the Company  suspended
the operations of its subsidiary, American Laser Corporation. Subsequent to that
date the Board of Directors decided to permanently discontinue the operations of
American Laser  Corporation and sell its assets.  The assets,  liabilities,  and
condensed discontinued operations are as follows:

                                                                June 30,  2003
                                                               ---------------
   Assets:
             Cash                                              $        11,054
       Accounts receivable, net                                          6,583
       Inventories                                                       2,000
       Equipment and leasehold improvements, net                        38,388
                                                               ---------------

       Total assets of discontinued operations                 $        58,025
                                                               ---------------


          Liabilities:
              Accounts payable and accrued expenses            $       620,202
        Current capital lease obligation                                 4,681
                                                               ---------------

         Total liabilities of discontinued operations          $       624,883
                                                               ---------------

                                        8

<PAGE>
<TABLE>
<CAPTION>

                                                  Three Months Ended                 Six Months Ended
                                                       June 30,                          June 30,
                                                 2003              2002           2003             2002
                                              ------------    ------------    ------------     ------------
<S>                                           <C>             <C>             <C>              <C>
Revenues:
    Net sales                                 $     61,786    $    478,346    $    236,049     $    995,361
    Interest and other income                       13,350              53          13,379               88
                                              ------------    ------------    ------------     ------------

       Total revenue and other income               75,136         478,399         249,428          995,449

Costs and expenses:
    Cost of products sold                          132,718         347,797         366,245          747,987
    Selling, general and
      administrative                               137,027          61,437         215,064          131,317
    Research and development                         1,412          12,105           8,810           28,452
    Royalties                                           --           6,105           1,187           13,037
    Interest                                           897             718           1,510            2,304
    Asset impairment expense                       140,053              --         140,053               --
                                              ------------    ------------    ------------     ------------

             Total costs and expenses              412,107         428,162         732,869          923,097
                                              ------------    ------------    ------------     ------------

(Loss) income before income taxes                 (336,971)         50,237        (483,441)          72,352

Income tax (expense) benefit                            --              --              --               --
                                              ------------    ------------    ------------     ------------

Net (loss) income                             $   (336,971)   $     50,237    $   (483,441)    $     72,352
                                              ------------    ------------    ------------     ------------
</TABLE>

NOTE I - ASSET IMPAIRMENTS

         During the three months ended June 30, 2003, the Company  determined to
discontinue the operations of its  subsidiary,  American Laser  Corporation,  as
noted in Note H above. As a result of the Company's inability to generate future
income and cash flows,  and its  decision  to sell the assets of American  Laser
Corporation,  the Company  has  recorded  asset  impairment  charges  during the
quarter ended June 30, 2003 as follows:

         Inventory                                              $       76,544
         Equipment and leasehold improvements                           53,509
         Other assets                                                   10,000
                                                                --------------

             Total impairment of assets from
              discontinued operations                           $      140,053
                                                                --------------



                                        9

<PAGE>

NOTE J - SUBSEQUENT EVENTS

         Due to the lack of orders for the Company's  medical laser products and
the  resulting  lack of  income  and cash  flow,  on July 31,  2003 the Board of
Directors  decided to permanently  discontinue  the operations of American Laser
Medical,  Inc. dba A.R.C.  Laser Corporation and sell its assets. Its operations
have  ceased  and  management  is  currently  in the  process  of winding up its
affairs.

         On August 11,  2003,  the  Company  entered  into a stock  subscription
agreement with an entity, whereby the Company will sell a number of shares equal
to approximately  sixty-five  percent of its issued and outstanding  stock, at a
yet to be determined date, for $75,000.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

         This report contains certain forward-looking statements and information
relating to the Company that are based on the beliefs of  management  as well as
assumptions  made by, and information  currently  available to management.  Such
statements  reflect the current view of the Company respecting future events and
are subject to certain  risks,  uncertainties,  and  assumptions,  including the
risks and uncertainties noted throughout the document.  Although the Company has
attempted to identify  important  factors that could cause the actual results to
differ  materially,  there may be other  factors that cause the  forward-looking
statements not to come true as anticipated,  believed,  projected,  expected, or
intended.  Should one or more of these risks or  uncertainties  materialize,  or
should  underlying  assumptions  prove  incorrect,  actual  results  may  differ
materially from those  described  herein as  anticipated,  believed,  projected,
estimated, expected, or intended.

         The  following  discussion  should  be read  in  conjunction  with  the
consolidated  financial  statements and notes thereto appearing in the Company's
Annual Report on Form 10-KSB (file number 0-13316).

RESULTS OF OPERATIONS
---------------------

Three months ended June 30, 2003.

         Net sales from continuing  operations,  for the three months ended June
30,  2003 were  $40,346 as  compared  to $35,764  for the same period in 2002 an
increase of $4,582.


                                       10
<PAGE>

         Cost of  products  sold for the three  months  ended June 30, 2003 were
$38,563 as compared  to $53,102 for the same period in 2002,  a decrease of $14,
539 or 27 %, which was primarily due to a decrease in labor and overhead  costs.
As a percentage of net sales, cost of products sold was 96% for the three months
ended June 30, 2003 as compared to 148% for the same period in 2002.

         Selling,  general,  and  administrative  expenses  for the three months
ended June 30,  2003 were  $58,070 as compared to $95,335 for the same period in
2002,  a decrease of $37,265 or 39%.  This  decrease in  selling,  general,  and
administrative  expenses was the result of decreased  activity and  personnel in
continuing operations.

         Interest  expenses  for the three month period ended June 30, 2003 were
$9,155 as compared to $8,750 during the same period of 2002.  Interest  expenses
are  primarily  the  result of the  interest  accrued on two  convertible  notes
payable.

         The Company  recognized a net loss from  continuing  operations for the
three months ended June 30, 2003 of $65,442, or $.04 per share compared to a net
loss of  $121,420,  or $.07 per share for the same period in 2002, a decrease of
$55,978,  or $.03 per share.  This  decrease  in the net loss is  primarily  the
result of decreased activity and personnel in continuing operations.

         The Company  recognized a net loss from the discontinued  operations of
$336,971,  for the three months ending June 30, 2003,  compared to net income of
$50,237 for the same period during 2002.

         Inclusive of the discontinued operations, the Company experienced a net
loss for the three months  ending June 30, 2003 of  $402,413,  or $.24 per share
compared to a net loss of $71,183 or $.04 per share for the same period in 2002.

         On  April  7,  2003,  the  Company  suspended  the  operations  of its
subsidiary,  American  Laser  Corporation,  and its  operations are presented in
discontinued  operations.  Subsequent  to June 30, 2003,  the Board of Directors
decided to  permanently  discontinue  the  operations of American Laser Medical,
Inc. dba, A.R.C.  Laser  Corporation and sell its assets. As of the date of this
filing,  the  Company  has ceased all  active  operations  and is winding up the
affairs of its subsidiaries, which have been dissolved.

Six months ended June 30, 2003.

         Net sales from continuing operations, for the six months ended June 30,
2003 were $77,543 as compared to $224,455 for the same period in 2002 a decrease
of $146,912  or 65%.  This  decrease  was the result of  decreased  sales of the
Company's medical laser equipment.

         Cost of  products  sold for the six  months  ended  June 30,  2003 were
$100,349  as compared  to  $237,430  for the same period in 2002,  a decrease of
$137,081  or 58 %,  which was  primarily  due to the  decrease  in  sales.  As a
percentage of net sales, cost of products sold was 129% for the six months ended
June 30, 2003 as compared to 106% for the same period in 2002.  This  percentage
increase  in the cost of  products  sold was  primarily  the  result of a larger
percentage  decrease  in sales  compared to the  percentage  decrease in cost of
sales, including certain fixed costs.


                                       11
<PAGE>

         Selling,  general, and administrative expenses for the six months ended
June 30, 2003 were  $97,342 as compared to $194,633 for the same period in 2002,
a  decrease  of  $97,291  or  50%.  This  decrease  in  selling,   general,  and
administrative  expenses was primarily the result of reduced marketing and sales
costs and decreased activity and personnel in continuing operations.

         Interest  expenses  for the six month  period  ended June 30, 2003 were
$17,911 as  compared to $17,500 of  interest  expense  during the same period of
2002.  Interest expenses are primarily the result of the interest accrued on two
convertible notes payable.

         The Company  recognized a net loss from  continuing  operations for the
six months ended June 30, 2003 of $138,059,  or $.08 per share compared to a net
loss of  $225,103,  or $.14 per share for the same period in 2002, a decrease of
$87,044,  or $.06 per share.  This  decrease  in the net loss is  primarily  the
result of  decreased  marketing  and  sales  costs and  decreased  activity  and
personnel in continuing operations.

         The Company  recognized a net loss from the discontinued  operations of
$409,130,  for the six months  ending June 30,  2003,  compared to net income of
$72,352 for the same period during 2002.

         Inclusive of the discontinued operations, the Company experienced a net
loss for the six months  ending  June 30, 2003 of  $621,500,  or $.38 per share,
compared  to a net loss of  $152,751  or $.09 per share  for the same  period in
2002.

         On  April  7,  2003,  the  Company  suspended  the  operation's  of its
subsidiary,  American  Laser  Corporation,  and its  operations are presented in
discontinued  operations.  Subsequent  to June 30, 2003,  the Board of Directors
decided to  permanently  discontinue  the  operations of American Laser Medical,
Inc. dba, A.R.C.  Laser  Corporation and sell its assets. As of the date of this
filing,  the  Company  has ceased all  active  operations  and is winding up the
affairs of its subsidiaries, which have been dissolved.

LIQUIDITY AND CAPITAL RESOURCES

         On June 30, 2003, the Company's continuing  operations had a deficit in
working  capital of  $1,785,654  as compared to a deficit in working  capital of
$1,069,427  at December  31,  2002,  an increase in working  capital  deficit of
$716,227.  This  decrease  in working  capital was  primarily  the result of the
Company's net loss, the discontinued operation and sale of assets.

         The  Company's  continuation  as a going  concern is  dependent  on its
ability to generate sufficient income and cash flow to meet its obligations on a
timely basis, to obtain additional financing as may be required. The Company has
ceased active  operations and therefore is unable to generate any income or cash
flow from  operations.  No assurances can be given that the Company will be able
to continue as a going concern.


                                       11
<PAGE>

ITEM 3.  CONTROLS AND PROCEDURES

         (a) Evaluation of disclosure controls and procedures

         Based on their evaluations as of June 30, 2003, the principal executive
officer and principal  financial  officer of the Company have concluded that the
Company's  disclosure  controls and  procedures  (as defined in Rules  13a-14(c)
under the  Securities  Exchange  Act) are  effective to ensure that  information
required to be  disclosed  by the Company in reports  that the Company  files or
submits under the Securities Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the rules and forms of the SEC.

       (b) Changes in internal controls

         There were no significant changes in the Company's internal controls or
in other  factors  that  could  significantly  affect  these  internal  controls
subsequent to the date of their most recent evaluation. The Company did not need
to implement any corrective actions with regard to significant  deficiencies and
material weaknesses in its internal controls.

PART II.  OTHER INFORMATION
          -----------------

Item 1.  LEGAL PROCEEDINGS

         In May 2002,  Leon Cohn,  M.D.  filed an action in Florida  against the
Company for breach of contract on a purchase agreement entered into for a Dodick
Laser  PhotoLysis  System.  Dr.  Cohn is  seeking  to  obtain  a  refund  of the
approximately  $100,000  purchase  price and  return  the  system.  The  Company
disputes  the  right of Dr.  Cohn to  return  the  System  and  obtain a refund.
Discovery  in this  action  was  commenced  and the  Company  filed an answer on
October 1, 2002 but since then the  Plaintiff  has done nothing to move the case
forward.

         During 2002,  two unrelated  parties which had entered into  agreements
with the Company to purchase Dodick Laser PhotoLysis  Systems claimed a right to
terminate their purchase agreements.  To resolve the dispute, the Company agreed
to accept  return of the  systems  and to repay the  purchase  price in  monthly
payments.  The Company has been unable to make the monthly payment  obligations.
These  parties have  threatened to commence  legal action,  but to our knowledge
have not yet done so.

         The Company in involved in certain  additional  legal  actions which it
considers  generally routine to its business activities or which involved claims
which,  if decided  adversely to the company,  would not  materially  affect the
consolidated financial statements of the Company.

ITEM 5.  OTHER INFORMATION

         Due to the lack of orders  for the  Company's  laser  products  and the
resulting lack of income and cash flow, on April 7, 2003, the Company  suspended
the operation of its subsidiary, American Laser Corporation.  Subsequent to that
date the Board of Directors decided to permanently discontinue the operations of
American Laser  Corporation and sell its assets. On July 28, 2003 American Laser
Corporation was dissolved.


                                       12
<PAGE>

         On July 31,  2003,  American  Laser  Medical,  Inc.,  dba A.R.C.  Laser
Corporation, was also dissolved due to lack of sales. Its operations have ceased
and management is currently in the process of closing this operation and winding
up its affairs.

         The Company had fallen  behind in the  payment of its  facility  rental
obligations and the landlord  notified the Company of default and requested that
the Company  vacate the  premises.  The Company  has  temporarily  leased a much
smaller facility and relocated.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         1. Exhibits

         Exhibit 31.1   Certification   Pursuant   to   Section   302  of  the
                        Sarbanes-Oxley Act of 2002.

         Exhibit 31.2   Certification   Pursuant   to   Section   302  of  the
                        Sarbanes-Oxley Act of 2002.

         Exhibit 32     Certification Pursuant to 18 U.S.C. Section 1350, as
                        Adopted Pursuant to Section 906 of the Sarbanes-Oxley
                        Act of 2002.

         2. Reports on Form 8-K.

         No reports on Form 8-K have been filed  during the  quarter  ended June
30, 2003.

                                       13
<PAGE>

                                   SIGNATURES


         In accordance with the  requirements of the Securities  Exchange Act of
1934,  the  registrant  caused  this  report to be  signed on its  behalf by the
undersigned thereunto duly authorized.




                                               LASER CORPORATION


    Date:   August 19, 2003                   /s/ B. Joyce Wickham
           ----------------                   ----------------------------------
                                              B. Joyce Wickham
                                              President, Chief Executive Officer
                                              and Director

    Date:   August 19, 2003                   /s/ Mark L. Ballard
          -----------------                   ----------------------------------
                                              Mark L. Ballard
                                              Vice President, Treasurer,
                                              Assistant Secretary and Director



                                       14